Actively Recruiting
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Led by Loma Linda University · Updated on 2025-06-05
400
Participants Needed
1
Research Sites
129 weeks
Total Duration
On this page
Sponsors
L
Loma Linda University
Lead Sponsor
I
Irrimax Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.
CONDITIONS
Official Title
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Singleton pregnancy
- Planned cesarean delivery at gestational age 37 weeks or later at Loma Linda University Children's Hospital
- Planned post-operative follow up with Loma Linda OBGYN
- Speak English or Spanish
- At least one of the following medical complications: Obesity BMI>= 30kg/m2, Diabetes, Spontaneous rupture of membranes, Intraamniotic infection
You will not qualify if you...
- Emergency cesarean delivery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Loma Linda University
Loma Linda, California, United States, 92354
Actively Recruiting
Research Team
N
Nikia Gray-Hutto, AS
CONTACT
A
Ashra Denise Tugung, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here